Optogenetics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Optogenetics Market By Product Type (Sensors, Actuators, Light equipment), By Technique (Viral vectors, Transgenic animals, Cre-Dependant Expression system), By Application (Neuroscience, Behavioural science, Cardiovascular diseases, Retinal disease treatment, Others), By End User (Pharmaceutical & Biopharmaceutical companies, Biotechnology companies, Academic research institutes) and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Optogenetics Market size was valued at USD 521.6 million in 2021, and is expected to reach USD 652.21 million by 2028, growing at a CAGR of 3.9% from 2022 – 2028. Optogenetics is the biological technique in neuroscience used for controlling the cells in the living tissue with the help of a light. Optogenetics is majorly used for monitor and control the activities of neurons in living tissue. Light-sensitive proteins are used as key reagents in the optogenetics. The neuronal control achieved by using optogenetic actuators such as halorhodopsin, channelrhodopsin, and archaerhodopsin. Optical recording of the neuronal activities made with optogenetic sensors for the neurotransmitter, membrane voltage, vesicular release, or calcium. Optogenetics is adopted in the ophthalmology, cardiology, behavioural science, neuroscience, and others. Increase in the adoption of optogenetics in the behavioural and neuroscience, technological advancements in optogenetics, growth in ultrafast laser tool technology are the key factors driving the growth of the market. Moreover, rise in the number of research laboratories adopting optogenetics technology around the globe and development in the genetic engineering research expected to propel the optogenetics market over the forecast period. However, a high cost of the technology, lack of awareness about the optogenetics, and the dearth of skilled professionals for optogenetic research might hamper the market over the forecast period.

Optogenetics Market

MARKET SUMMARY
-
3.9%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 3.9%
  • Largest Market– North America
  • Fastest Growing Market–  Europe

Optogenetics Market

  • The report on global optogenetics market gives historical, current and future market sizes (US$ Mn) based on product type, targeting technology, application, and end user and geographical regions.
  • Optogenetics Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Key Players
  • Coherent, Inc.
  • Thorlabs, Inc.
  • Regenexbio, Inc
  • Jackson Laboratory
  • Laserglow Technologies
  • GenSight Biologics S.A
Optogenetics Market Growth

Global optogenetics market is growing at a significant CAGR owing to rise in the adoption of optogenetics technology in neuroscience and behavioural science. An innovation of newer technologies for various diseases such as obesity and retinal diseases on optogenetics platform might fuel the market growth in near future. For instance, in August 2015, Boehringer Ingelheim and Circuit therapeutic have collaborated to develop the novel medicines for obesity on optogenetics technology platform. Acquisitions and mergers, collaborations, technological advancements, and fundraising are the strategies adopted by the companies for increasing their revenue in optogenetics market. For instance, in November 2015, RetroSense Therapeutics secured US$ 6Mn Series B financing from various organizations for the clinical development of RST-001 for the treatment of Retinitis pigmentosa. Moreover, in November 2016, Bruker targeted on optogenetics market by commercializing NeuraLight 3D an optical module for stimulating and imaging the multiple neurons.


North-America Got Significant Share

Optogenetics Market

Geographically, optogenetics market is segmented into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. Increase in the R&D activities in neuroscience and optogenetics and availability of professional researchers in North America is anticipated to create demand for optogenetics research in the region. Moreover, the market is developing in the Europe region owing to collaboration between the companies for developing newer technologies on optogenetics platform. However, technological developments in market, increase in the applications of optogenetics, and rise in R&D activities in Asia Pacific region plays a key role in optogenetics market growth.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In January 2017, Applied Genetic Technology Corporation and Bionic Sight collaborated for the development of optogenetic therapy and device for the treatment of visual deficits and blindness
  • In September 2016, Allergan acquired RetroSense Therapeutics for the development of RST-001 used in the treatment of retinitis pigmentosa.

Key

Key Features of the Report

Optogenetics Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The optogenetics market is projected to expand at a CAGR of 3.9% during the forecast period

Coherent, Inc., Noldus Information technology, Thorlabs, Inc., Bruker, Laserglow Technologies, Regenexbio, Inc, GenSight Biologics S.A, Jackson Laboratory

North America is the fastest-growing region for the optogenetics market


Report

Table Of Content


Report

Company Profile

  • Coherent, Inc. (U.S.)
  • Noldus Information technology (Netherlands)
  • Thorlabs, Inc. (U.S.)
  • Bruker (U.S.)
  • Laserglow Technologies (Canada)
  • Regenexbio, Inc. (U.S.)
  • GenSight Biologics S.A. (France)
  • Jackson Laboratory (U.S.)
  • Applied Genetic Technologies Corporation (U.S.)
  • Circuit Therapeutics, Inc. (U.S.)

Description

Optogenetics Market size was valued at USD 521.6 million in 2021, and is expected to reach USD 652.21 million by 2028, growing at a CAGR of 3.9% from 2022 – 2028. Optogenetics is the biological technique in neuroscience used for controlling the cells in the living tissue with the help of a light. Optogenetics is majorly used for monitor and control the activities of neurons in living tissue. Light-sensitive proteins are used as key reagents in the optogenetics. The neuronal control achieved by using optogenetic actuators such as halorhodopsin, channelrhodopsin, and archaerhodopsin. Optical recording of the neuronal activities made with optogenetic sensors for the neurotransmitter, membrane voltage, vesicular release, or calcium. Optogenetics is adopted in the ophthalmology, cardiology, behavioural science, neuroscience, and others. Increase in the adoption of optogenetics in the behavioural and neuroscience, technological advancements in optogenetics, growth in ultrafast laser tool technology are the key factors driving the growth of the market. Moreover, rise in the number of research laboratories adopting optogenetics technology around the globe and development in the genetic engineering research expected to propel the optogenetics market over the forecast period. However, a high cost of the technology, lack of awareness about the optogenetics, and the dearth of skilled professionals for optogenetic research might hamper the market over the forecast period.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX